Skip to main content
. 2011 Nov 1;34(11):1479–1486. doi: 10.5665/sleep.1380

Table S4.

Therapy-related adverse events by severity

Severity Adverse Event No. subjects with event
    Mild Skin irritation (soreness, itchiness) 3
    Mild Nausea/vomiting 1
    Mild Tongue soreness 1
    Mild Pain or discomfort due to electrical stimulation 1
    Mild Change in salivary flow 1
    Mild Tongue abrasion with or without visible lesion(s) 4
Total with at least 1 mild adverse event 9/21
    Moderate Pain 1
    Moderate Tongue muscle fatigue, weakness or soreness 3
    Moderate Tongue abrasion with or without visible lesion(s) 8
    Moderate Bruising 1
    Moderate Lip Weakness 1
    Moderate Genitourinary abnormality 1
    Moderate Abnormal scarring (keloid or hypertrophic) 1
    Moderate Musculoskeletal abnormality 1
Total with at least 1 moderate adverse event 9/21
    Severe Infection* 1
    Severe Cuff dislodgement* 1
Total with at least 1 severe adverse event 2/21

Adverse events determined by the Clinical Events Committee to be related to HGNS therapy. Totals refer to number of patients with an event (i.e., one subject may have had > 1 event of a given severity).

*

Serious adverse event, also considered to be related to the implant procedure.